Increased cell proliferation most likely plays a key role in peroxisome pro
liferator-induced liver cancer. Recently, Kupffer cells were shown to be re
sponsible for Wy-14,643-induced cell proliferation. However, the mechanism
by which peroxisome proliferators activate Kupffer cells is unknown. Since
gut-derived endotoxin is a known activator of Kupffer cells, the hypothesis
that it is involved was evaluated. Increased cell proliferation and peroxi
some induction were unaffected by gut sterilization, Moreover, endotoxin wa
s not detectable in portal blood following treatment with Wy-14,643, Theref
ore, it is concluded that gut-derived endotoxin is not responsible for Kupf
fer cell activation. To test the hypothesis that Kupffer cells are activate
d by Wy-14,643 directly, Kupffer cell superoxide production was measured fo
llowing treatment in vitro, Wy-14,643 increased superoxide production in a
dose-dependent manner (0.1 and 50 mu M) with half-maximal stimulation at 2.
5 mu M Diethylhexylphthalate (DEHP) and ethylhexanol did not increase super
oxide production even at doses 50 times higher than Wy-14,643; however, mon
oethylhexylphthalate (MEHP) activated superoxide production as effectively
as Wy-14,643 with half-maximal stimulation at 5 mu M. Treatment with Wy-14,
643 for 21 days caused a 2-fold increase in Kupffer cell superoxide product
ion while DEHP did not. Pretreatment of Kupffer cells with staurosporine (0
.01-10 pM) completely blocked generation of superoxide demonstrating that p
rotein kinase C is required. Moreover, Wy-14,643 increased Kupffer cell pro
tein kinase C activity 3-fold. Pretreatment of Kupffer cells with the amino
acid glycine (0.01-3 mM), which blunts calcium signaling, inhibited Wy-14,
643-stimulated superoxide production and increased protein kinase C activit
y completely. These data are consistent with the hypothesis that potent per
oxisome proliferators (Wy-14,643 and MEHP) directly activate Kupffer cell p
roduction of oxidants via mechanisms involving protein kinase C, Further, p
eroxisome proliferator treatments that sustain elevated rates of cell proli
feration (e.g. Wy-14,643) activate Kupffer cell superoxide production follo
wing long-term dietary treatment supporting the hypothesis that Kupffer cel
l-derived oxidants are involved in peroxisome proliferator-induced neoplasi
a.